Note: Ingredients listed on restricted chemical lists
EC/CAS
209-150-3/557-04-0
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
0.1 - 0.4
EC/CAS
200-559-2
Name of the chemical
Lactose C12H22O11
Concentration
98-<100
General Information
Revision date
2021-09-15
Product name
FLUTICASONE FUROATE/ VILANTEROL DRY POWDER INHALER
Product Synonyms
RELVAR ELLIPTA * BREO ELLIPTA * REVINTY ELLIPTA * REVINTY ELLIPTA 184/22 MCG
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360, H411
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
H411
Toxic to aquatic life with long lasting effects
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended.
Health hazards
Reproductive toxicity Category 1B H360 - May damage fertility or the unborn child.
Environmental hazards
Hazardous to the aquatic environment, Category 2 H411 - Toxic to aquatic life with long-term aquatic hazard long lasting effects. Hazard summary Caution - Pharmaceutical agent. May cause reproductive effects. Dangerous for the environment if discharged into watercourses. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
FLUTICASONE FUROATE, LACTOSE, MONOHYDRATE, MAGNESIUM STEARATE, VILANTEROL TRIPHENYLACETIC ACID SALT
Signal word
Danger
Hazard statements
H360 May damage fertility or the unborn child. H411 Toxic to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/attention. P391 Collect spillage.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
Supplemental label elements
1 % of the mixture consists of component(s) of unknown acute oral toxicity. 100 % of the mixture consists of component(s) of unknown acute dermal toxicity. 100 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 100 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.